GERMINAL CENTER INTERACTIONS OF NORMAL/MALIGNANT B CELLS
GERMINAL CENTER INTERACTIONS OF NORMAL/MALIGNANT B CELLS
批准号:
2096411
负责人:
Arnold S. Freedman
金额:
$17.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-07-08 至 1999-05-31
中文摘要
滤泡性淋巴瘤是不治之症。从形态上看,它们
概述了继发性骨肉瘤正常生发中心的结构。
淋巴滤泡。滤泡性淋巴瘤常见的独特成分和
正常的生发中心是滤泡树突状细胞(FDC)。FDC是
生发中心微环境中的主要支持细胞
B细胞正常分化。假设FDDC对以下各项至关重要
调节正常B细胞的生长和分化为记忆或
抗体分泌细胞。B细胞与FDCs的相互作用是介导性的
VLA-4主要通过黏附受体参与B细胞信号传导
通过激活酪氨酸激酶通路来激活细胞。最近的证据
提示整合素介导的信号转导对细胞的生长和
正常和恶性细胞的存活,这可能对控制很重要
程序性细胞死亡。在这方面要研究的一个中心假设
有人提出,β1整合素介导的信号转导从根本上说是
对调节B细胞的生长和存活很重要。用胶合体
淋巴瘤中,FDCs与肿瘤B细胞的黏附作用是
完好无损,并使用相同的受体-配体对。目前,有
对疾病控制中心对正常的影响的性质的认识有限
B细胞以及FDCs是否可以影响恶性B细胞的生长。这个
这个项目的主要目标是研究Normal
伴有FDCs的肿瘤性B细胞。为此,我们计划开展四项工作
明确的目标。首次研究Beta1整合素介导的信号转导
酪氨酸磷酸化对正常和恶性B细胞的影响
蛋白质。二是优化体外扩增条件
FDC的维护和维护。第三,检查疾病控制中心的影响
对正常B细胞生长存活的影响及信号识别
它们会调节这些影响。第四,研究金融中心对经济发展的影响
滤泡性淋巴瘤细胞的生长和存活。对这一概念的理解
FDC和FDC之间可能发生的细胞间相互作用和信号转导
滤泡性淋巴瘤细胞可能为未来的治疗策略提供
来调节这些肿瘤的生长。
英文摘要
Follicular lymphomas are incurable diseases. Morphologically, they
recapitulate the architecture of normal germinal centers of secondary
lymphoid follicles. A unique component common to follicular lymphomas and
normal germinal centers is the follicular dendritic cell (FDC). FDCs are
athe major supporting cell in the germinal center microenvironment in which
B cells normally differentiate. FDCs are hypothesized to be essential to
the regulation of normal B cell growth and differentiation into memory or
antibody secreting cells. The interaction of B cells with FDCs is mediated
principally by the adhesion receptor VLA -4 is involved in signaling to B
cells through activation of the tyrosine kinase pathway. Recent evidence
suggests that integrin mediated signaling is critical to the growth and
survival of normal and malignant cells, and may be important to the control
of programmed cell death. A central hypothesis to be investigated in this
proposal is that beta1 integrin mediated signaling is fundamentally
important to the regulation of B cell growth and survival. In collicular
lymphomas, the adhesive interaction of FDCs with neoplastic B cells is
intact and employs the same receptor-ligand pair. Presently, there is
limited understanding of the nature of the influences of FDCs upon normal
B cells and whether FDCs they can affect malignant B cell growth . The
primary goal of this project is to investigate the interactions of normal
and neoplastic B cells with FDCs. To this end we plan to undertake four
Specific Aims. First to investigate beta1 integrin mediated signaling in
normal and malignant B cells through studies of tyrosine phosphorylated
proteins. Second to optimize the in vitro conditions for expansion and
maintenance and maintenance of FDCs. Third to examine the effects of FDCs
on the growth and survival of normal B cells and to identify the signals
which mediate those effects. Fourth to examine the effects of FDCs on the
growth and survival of follicular lymphoma cells. An understanding of the
cell-cell interactions and signaling which may occur between FDCs and
follicular lymphoma cells may provide future therapeutic strategies with
which to modulate the growth of these tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CpG Plus Rituximab Therapy in Follicular Lymphoma
-
批准号:6792326
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2004
-
负责人:Arnold S. Freedman
-
依托单位:
CpG Plus Rituximab Therapy in Follicular Lymphoma
-
批准号:6889316
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2004
-
负责人:Arnold S. Freedman
-
依托单位:
Etanercept Therapy in Follicular Lymphoma
-
批准号:6585639
-
项目类别:
-
资助金额:$28.47万
-
财政年份:2002
-
负责人:Arnold S. Freedman
-
依托单位:
Etanercept Therapy in Follicular Lymphoma
-
批准号:6660312
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2002
-
负责人:Arnold S. Freedman
-
依托单位:
TRANSLATIONAL THERAPEUTIC STRATEGIES FOR LOW GRADE LYMPHOMA
-
批准号:6314043
-
项目类别:
-
资助金额:$22.61万
-
财政年份:2000
-
负责人:Arnold S. Freedman
-
依托单位:
INTEGRIN SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIA
-
批准号:6174196
-
项目类别:
-
资助金额:$16.65万
-
财政年份:1999
-
负责人:Arnold S. Freedman
-
依托单位:
INTEGRIN SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIA
-
批准号:2841610
-
项目类别:
-
资助金额:$16.27万
-
财政年份:1999
-
负责人:Arnold S. Freedman
-
依托单位:
TRANSLATIONAL THERAPEUTIC STRATEGIES FOR LOW GRADE LYMPHOMA
-
批准号:6103050
-
项目类别:
-
资助金额:$22.61万
-
财政年份:1999
-
负责人:Arnold S. Freedman
-
依托单位:
INTEGRIN SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIA
-
批准号:6377170
-
项目类别:
-
资助金额:$17.05万
-
财政年份:1999
-
负责人:Arnold S. Freedman
-
依托单位:
TRANSLATIONAL THERAPEUTIC STRATEGIES FOR LOW GRADE LYMPHOMA
-
批准号:6269697
-
项目类别:
-
资助金额:$22.86万
-
财政年份:1998
-
负责人:Arnold S. Freedman
-
依托单位:
TRANSLATIONAL THERAPEUTIC STRATEGIES FOR LOW GRADE LYMPHOMA
-
批准号:6237543
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1997
-
负责人:Arnold S. Freedman
-
依托单位:
GERMINAL CENTER INTERACTIONS OF NORMAL/MALIGNANT B CELLS
-
批准号:2429747
-
项目类别:
-
资助金额:$17.75万
-
财政年份:1991
-
负责人:Arnold S. Freedman
-
依托单位:
GERMINAL CENTER ADHESION OF NORMAL/NEOPLASTIC B CELLS
-
批准号:2096409
-
项目类别:
-
资助金额:$19.09万
-
财政年份:1991
-
负责人:Arnold S. Freedman
-
依托单位:
GERMINAL CENTER INTERACTIONS OF NORMAL/MALIGNANT B CELLS
-
批准号:2096413
-
项目类别:
-
资助金额:$17.4万
-
财政年份:1991
-
负责人:Arnold S. Freedman
-
依托单位:
GERMINAL CENTER ADHESION OF NORMAL/NEOPLASTIC B CELLS
-
批准号:3199670
-
项目类别:
-
资助金额:$18.42万
-
财政年份:1991
-
负责人:Arnold S. Freedman
-
依托单位:
GERMINAL CENTER INTERACTIONS OF NORMAL/MALIGNANT B CELLS
-
批准号:2712652
-
项目类别:
-
资助金额:$18.13万
-
财政年份:1991
-
负责人:Arnold S. Freedman
-
依托单位:
GERMINAL CENTER ADHESION OF NORMAL/NEOPLASTIC B CELLS
-
批准号:3199668
-
项目类别:
-
资助金额:$17.5万
-
财政年份:1991
-
负责人:Arnold S. Freedman
-
依托单位:
NCI PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM
-
批准号:3079608
-
项目类别:
-
资助金额:$6.33万
-
财政年份:1986
-
负责人:Arnold S. Freedman
-
依托单位:
NCI PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM
-
批准号:3079604
-
项目类别:
-
资助金额:$5.77万
-
财政年份:1986
-
负责人:Arnold S. Freedman
-
依托单位:
NCI PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM
-
批准号:3079607
-
项目类别:
-
资助金额:$6.05万
-
财政年份:1986
-
负责人:Arnold S. Freedman
-
依托单位:
国内基金
海外基金
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
-
批准号:TGY24H080011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李鸿鹄
-
依托单位: